health pharma news today obesity drugs glp-1 Most do not improve quality of life or heart health, analysis indicates GLP-1 Pill Helped People With

Access the complete GLP-1 Pipeline Update table for November 2025

Optimizing dosing schedules and administration routes is critical to maximize therapeutic efficacy while minimizing adverse effects such as hypoglycemia and gastrointestinal intolerance

Patients with a BMI of 27 or higher may also qualify if they have a history of certain conditions including prediabetes, prior heart attack, or stroke

Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes

Along the way, researchers began noticing something unexpected

The company plans to submit orforglipron for approval as an obesity medication to global regulatory agencies by the end of the year, and as a diabetes medication in 2026